1 | 24019208 | A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. | Mol Cancer Ther | 2014 Mar |
3 |
2 | 25749177 | Targeting mcl-1 for radiosensitization of pancreatic cancers. | Transl Oncol | 2015 Feb |
4 |
3 | 28337703 | UMI-77 primes glioma cells for TRAIL-induced apoptosis by unsequestering Bim and Bak from Mcl-1. | Mol Cell Biochem | 2017 Aug |
13 |
4 | 28659182 | Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. | BMC Cancer | 2017 Jun 28 |
5 |
5 | 30479840 | Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1. | Cell Death Discov | 2018 |
1 |
6 | 30796196 | Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477. | Cell Death Dis | 2019 Feb 22 |
2 |
7 | 32737157 | Targeting the Synthetic Vulnerability of <i>PTEN</i>-Deficient Glioblastoma Cells with MCL1 Inhibitors. | Mol Cancer Ther | 2020 Oct |
1 |
8 | 33184293 | Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer's disease mouse model. | Nat Commun | 2020 Nov 12 |
2 |
9 | 33342330 | Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease. | Autophagy | 2021 Mar |
3 |
10 | 35524750 | Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis. | FASEB J | 2022 Jun |
2 |